Table 1 Main characteristics of patients included in our study
From: Serum 25-hydroxy vitamin D levels in age-related macular degeneration
AMD Group (n = 93) | Control Group (n = 93) | p | |
|---|---|---|---|
Age, mean ± SD | 78.96 ± 8.5 | 78.8 ± 8.4 | 0.970 |
Gender | |||
Female | 57 (61.3%) | 54 (58.1%) | 0.654 |
Male | 36 (38.7%) | 39 (41.9%) | |
Levels Vit D, median ± IQR | 15 ± 10 | 21 ± 14 | 0.004 |
Sufficiency | 10 (10.8%) | 19 (20.4%) | 0.013 |
Insufficiency | 21 (22.6%) | 34 (36.6%) | |
Deficiency | 47 (50.5%) | 29 (31.2%) | |
Severe deficiency | 15 (16.1%) | 11 (11.8%) | |
Normal | 10 (10.8%) | 19 (20.4%) | 0.069 |
Pathological | 83 (89.2%) | 74 (79.6%) | |
Sufficiency + insufficiency | 31 (33.3%) | 53 (57%) | 0.001 |
Deficiency + severe deficiency | 62 (66.7%) | 40 (43%) | |